Exits included Helmholtz-founded contract research business Inamed and Hannover Medical School chip cytometry spinout Zellkraftwerk.
Germany-based multi-university tech transfer unit Ascenion capped three portfolio exits during 2019 although the total return dropped to €2.3m ($3.1m) from $5.4m in 2018.
The unit held a total of 23 shareholdings by the end of 2019, two of which were acquired during the period.
Ascenion said it had witnessed delays launching new spinouts due to diverging interests of different stakeholders.
The company proposes to respond with a new framework for licensing and equity conditions in the…
